Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Panbela Therapeutics ( (PBLA) ).
On February 12, 2025, Panbela Therapeutics, Inc. announced a reduction in the annual compensation for their CEO and President, Jennifer K. Simpson, and their VP of Finance and CFO, Susan Horvath. Dr. Simpson’s new annual salary is approximately $30,200, while Ms. Horvath’s is $23,150, reflecting a significant adjustment in executive compensation.
More about Panbela Therapeutics
YTD Price Performance: -24.44%
Average Trading Volume: 18,279
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.65M
For a thorough assessment of PBLA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- Boeing Stock (NYSE:BA) Notches Up as Strike Starts to Hurt
- “You’re Going to Burn This Billion Dollars.” Microsoft Stock (NASDAQ:MSFT) Slumps on Original Assessment of OpenAI
- “7.5 Years Has Felt like a Long Time to Wait.” Sam Altman Wants His Roadster Deposit Back, Tesla Stock (NASDAQ:TSLA) Jumps Regardless